Ching‐Hon Pui

4.7k total citations · 3 hit papers
52 papers, 3.3k citations indexed

About

Ching‐Hon Pui is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Ching‐Hon Pui has authored 52 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 27 papers in Pediatrics, Perinatology and Child Health and 16 papers in Hematology. Recurrent topics in Ching‐Hon Pui's work include Acute Lymphoblastic Leukemia research (37 papers), Childhood Cancer Survivors' Quality of Life (24 papers) and Acute Myeloid Leukemia Research (12 papers). Ching‐Hon Pui is often cited by papers focused on Acute Lymphoblastic Leukemia research (37 papers), Childhood Cancer Survivors' Quality of Life (24 papers) and Acute Myeloid Leukemia Research (12 papers). Ching‐Hon Pui collaborates with scholars based in United States, Singapore and United Kingdom. Ching‐Hon Pui's co-authors include Mary V. Relling, Maurizio Aricò, Andrea Biondi, William E. Evans, William E. Evans, Charles R. Yates, Eugene Y. Krynetski, Hung-Liang Tai, Thrina Loennechen and Michael Y. Fessing and has published in prestigious journals such as Blood, Annals of Internal Medicine and Hepatology.

In The Last Decade

Ching‐Hon Pui

52 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

1997 583 citations Ching‐Hon Pui, Mary V. Relling et al. profile →
L‐asparaginase treatment in acute lymphoblastic leukemia

2010 445 citations Ching‐Hon Pui et al. Cancer profile →
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

2018 403 citations Mary V. Relling, Matthias Schwab et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching‐Hon Pui United States	24	1.8k	1.4k	796	764	533	52	3.3k
Deqing Pei United States	40	3.3k 1.9×	2.3k 1.7×	1.5k 1.9×	1.8k 2.4×	1.0k 1.9×	85	5.8k
Anthony M. Marinaki United Kingdom	32	1.4k 0.8×	539 0.4×	916 1.2×	298 0.4×	349 0.7×	85	3.2k
Yaddanapudi Ravindranath United States	41	2.2k 1.3×	1.1k 0.8×	1.5k 1.9×	2.7k 3.5×	844 1.6×	180	5.5k
Hiroto Inaba United States	42	3.1k 1.8×	1.8k 1.3×	1.4k 1.8×	3.0k 3.9×	1.9k 3.6×	173	6.7k
Marc Ansari Switzerland	26	566 0.3×	582 0.4×	538 0.7×	449 0.6×	406 0.8×	161	2.0k
Stefan Söderhäll Sweden	26	819 0.5×	514 0.4×	851 1.1×	430 0.6×	435 0.8×	69	2.1k
Thomas J. Neuhaus Switzerland	30	224 0.1×	560 0.4×	1.4k 1.8×	427 0.6×	297 0.6×	107	3.5k
Lutz T. Weber Germany	30	363 0.2×	841 0.6×	734 0.9×	219 0.3×	205 0.4×	155	3.5k
Samart Pakakasama Thailand	25	408 0.2×	375 0.3×	434 0.5×	472 0.6×	334 0.6×	130	1.6k
Denis R. Miller United States	30	720 0.4×	654 0.5×	412 0.5×	985 1.3×	296 0.6×	98	2.7k

Countries citing papers authored by Ching‐Hon Pui

Since Specialization

Citations

This map shows the geographic impact of Ching‐Hon Pui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hon Pui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hon Pui more than expected).

Fields of papers citing papers by Ching‐Hon Pui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Hon Pui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hon Pui. The network helps show where Ching‐Hon Pui may publish in the future.

Co-authorship network of co-authors of Ching‐Hon Pui

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Hon Pui. A scholar is included among the top collaborators of Ching‐Hon Pui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Hon Pui. Ching‐Hon Pui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Penkert, Rhiannon R., Bart G. Jones, Li Tang, et al.. (2024). Association of Vitamin A and D Deficiencies with Infectious Outcomes in Children Undergoing Intensive Induction Therapy for Acute Lymphoblastic Leukemia. The Journal of Pediatrics. 273. 114148–114148. 2 indexed citations

Hargest, Virginia, Stacey Schultz‐Cherry, Valerie Cortez, et al.. (2022). Human Astrovirus VA1 Encephalitis in Pediatric Patients With Cancer: Report of 2 Cases and Review of the Literature. Journal of the Pediatric Infectious Diseases Society. 11(9). 408–412. 10 indexed citations

Relling, Mary V., Matthias Schwab, Michelle Whirl‐Carrillo, et al.. (2018). Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. Clinical Pharmacology & Therapeutics. 105(5). 1095–1105. 403 indexed citations breakdown →

Conklin, Heather M., Yinmei Zhou, Jason M. Ashford, et al.. (2017). Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia. Pediatric Blood & Cancer. 64(8). 19 indexed citations

Richards, Sue, et al.. (2012). Systematic review and meta‐analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 60(2). 185–195. 66 indexed citations

Hudson, Melissa M., Joseph P. Neglia, William G. Woods, et al.. (2011). Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatric Blood & Cancer. 58(3). 334–343. 108 indexed citations

Hijiya, Nobuko, Clinton F. Stewart, Yinmei Zhou, et al.. (2008). Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse. Cancer. 112(9). 1983–1991. 17 indexed citations

Hinds, Pamela S., Marilyn Hockenberry, Jami S. Gattuso, et al.. (2007). Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer. 110(10). 2321–2330. 130 indexed citations

Rubnitz, Jeffrey E., Shelly Lensing, Yinmei Zhou, et al.. (2004). Death during induction therapy and first remission of acute leukemia in childhood. Cancer. 101(7). 1677–1684. 106 indexed citations

10.

Sandlund, John T., Scott C. Howard, Nobuko Hijiya, et al.. (2004). Myositis complicating viridans streptococcal sepsis in childhood leukemia. Pediatric Blood & Cancer. 44(3). 277–279. 6 indexed citations

11.

Edick, Mathew J., Cheng Cheng, Wenjian Yang, et al.. (2004). Lymphoid gene expression as a predictor of risk of secondary brain tumors. Genes Chromosomes and Cancer. 42(2). 107–116. 23 indexed citations

12.

Coustan‐Smith, Elaine, Raul C. Ribeiro, Jeffrey E. Rubnitz, et al.. (2003). Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. British Journal of Haematology. 123(2). 243–252. 94 indexed citations

13.

Pui, Ching‐Hon, Mary V. Relling, Dario Campana, & William E. Evans. (2002). Childhood acute lymphoblastic leukemia. PubMed. 6(2). 161–180. 79 indexed citations

14.

Fuscoe, James C., Nancy M. Hanley, R. Woodrow Setzer, et al.. (1998). The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 419(1-3). 107–121. 12 indexed citations

15.

Pui, Ching‐Hon. (1997). ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Clinics of North America. 44(4). 831–846. 42 indexed citations

16.

Murry, Daryl J., Timothy W. Synold, Ching‐Hon Pui, & John H. Rodman. (1995). Renal Function and Methotrexate Clearance in Children With Newly Diagnosed Leukemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(2). 144–149. 18 indexed citations

17.

Behm, Fred G., Ching‐Hon Pui, Guillermo O. Rangel Rivera, et al.. (1995). Acute lymphoblastic leukemias expressing NK cell-associated CD56 do not arise from NK cell progenitors. Modern Pathology. 8(1). 106. 1 indexed citations

18.

Mahmoud, Hazem H., Susan A. Ridge, Frederick G. Behm, et al.. (1995). Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins. Medical and Pediatric Oncology. 24(2). 77–81. 32 indexed citations

19.

Petros, William P., John H. Rodman, Michael Christensen, et al.. (1992). Variability in Teniposide Plasma Protein Binding Is Correlated With Serum Albumin Concentrations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(4). 273–277. 12 indexed citations

20.

Mahmoud, Hazem H., Michael J. Schell, & Ching‐Hon Pui. (1991). Cholelithiasis after treatment for childhood cancer. Cancer. 67(5). 1439–1442. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact